J Mullol Selected Research

Histamine Antagonists (Antihistamines)

1/2018	Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study.
1/2015	Update on rupatadine in the management of allergic disorders.
1/2013	Use of second generation H1 antihistamines in special situations.
1/2011	Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
1/2011	Clinical use of oral antihistamines and intranasal corticosteroids in patients with allergic rhinitis.
1/2011	Bilastine and the central nervous system.
1/2011	Effect of bilastine upon nasal obstruction.
1/2011	Rupatadine improves nasal symptoms, quality of life (ESPRINT-15) and severity in a subanalysis of a cohort of Spanish allergic rhinitis patients.
1/2011	Effect of antihistamine up-dosing in chronic urticaria.
1/2009	Allergic rhinitis and school performance.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Mullol Research Topics

Disease

19	Asthma (Bronchial Asthma) 04/2022 - 11/2000
18	Allergic Rhinitis 02/2020 - 10/2004
15	Nasal Polyps (Nasal Polyp) 04/2022 - 05/2000
11	Inflammation (Inflammations) 06/2021 - 02/2000
10	Rhinitis 11/2017 - 11/2000
9	Polyps 04/2022 - 05/2001
7	Rhinosinusitis 04/2022 - 04/2009
7	Hypersensitivity (Allergy) 01/2018 - 01/2007
5	Respiratory Tract Diseases (Respiratory Tract Disease) 08/2020 - 10/2004
4	Urticaria (Hives) 01/2013 - 01/2007
4	Chronic Urticaria 01/2011 - 01/2007
3	Cystic Fibrosis (Mucoviscidosis) 02/2020 - 07/2006
3	Nasal Obstruction 11/2017 - 01/2009
2	Seasonal Allergic Rhinitis (Hay Fever) 11/2022 - 01/2011
2	Anosmia 04/2022 - 01/2020
2	Eosinophilia 01/2022 - 01/2010
2	Conjunctivitis 01/2013 - 01/2011
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2011 - 01/2009
2	Hyperplasia 10/2008 - 11/2006
1	Hypertension (High Blood Pressure) 01/2022
1	Bronchiectasis 01/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Allergic Fungal Sinusitis 02/2020
1	Facial Pain (Myofacial Pain) 02/2020
1	Flushing 02/2020
1	COVID-19 01/2020
1	Infections 11/2017
1	Sneezing 11/2017
1	Rhinorrhea 11/2017
1	Frailty 01/2017
1	type 2C Congenital disorder of glycosylation 01/2017
1	Anaphylaxis (Anaphylactic Shock) 01/2017
1	Cold Urticaria 01/2015
1	Mastocytosis 01/2015
1	Bites and Stings (Sting) 01/2015
1	Liver Failure 01/2013
1	Amnesia (Dissociative Amnesia) 01/2013

Drug/Important Bio-Agent (IBA)

14	Histamine Antagonists (Antihistamines)IBA 01/2018 - 01/2007
11	AllergensIBA 11/2022 - 01/2007
9	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 05/2000
7	desloratadine (Aerius)FDA LinkGeneric 01/2017 - 01/2006
6	rupatadineIBA 01/2017 - 04/2008
5	Pharmaceutical PreparationsIBA 04/2022 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2004
5	CytokinesIBA 10/2010 - 05/2000
5	GlucocorticoidsIBA 03/2009 - 12/2000
5	Messenger RNA (mRNA)IBA 03/2009 - 02/2003
4	levocetirizine FDA LinkGeneric 01/2017 - 06/2005
4	Budesonide (Pulmicort)FDA LinkGeneric 01/2012 - 05/2001
4	bilastineIBA 01/2011 - 01/2011
3	Immunoglobulin E (IgE)IBA 01/2022 - 01/2007
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2020 - 11/2000
3	Prednisone (Sone)FDA LinkGeneric 01/2012 - 10/2008
3	SteroidsIBA 01/2012 - 05/2000
3	fexofenadine (Allegra)FDA LinkGeneric 01/2011 - 01/2011
3	Cetirizine (Zyrtec)FDA LinkGeneric 01/2011 - 04/2008
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2009 - 02/2003
3	ProstaglandinsIBA 01/2009 - 07/2006
3	glucocorticoid receptor betaIBA 10/2008 - 08/2004
2	Biological ProductsIBA 04/2022 - 08/2020
2	anti-IgE antibodiesIBA 04/2022 - 09/2006
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 09/2005
2	Monoclonal AntibodiesIBA 06/2021 - 01/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2018 - 04/2009
2	Nasal SpraysIBA 04/2018 - 01/2012
2	Platelet Activating FactorIBA 01/2017 - 01/2015
2	Hypnotics and Sedatives (Sedatives)IBA 01/2013 - 01/2011
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 10/2010 - 01/2007
2	EnzymesIBA 01/2009 - 07/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2009 - 07/2006
2	MucinsIBA 10/2008 - 04/2006
2	glucocorticoid receptor alphaIBA 10/2008 - 08/2004
2	Histamine (Histamine Dihydrochloride)FDA Link 04/2008 - 01/2007
2	NF-kappa B (NF-kB)IBA 06/2007 - 02/2003
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2006 - 05/2000
2	Nedocromil (Alocril)FDA Link 05/2001 - 05/2000
1	TabletsIBA 11/2022
1	benralizumabIBA 04/2022
1	mepolizumabIBA 04/2022
1	reslizumabIBA 04/2022
1	Omalizumab (Xolair)FDA Link 04/2022
1	Bronchodilator Agents (Bronchodilators)IBA 01/2022
1	dupilumabIBA 06/2021
1	Interleukin-13IBA 06/2021
1	Interleukin-4 (Interleukin 4)IBA 06/2021
1	Lidocaine (Xylocaine)FDA LinkGeneric 02/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Plant ExtractsIBA 04/2018
1	LipidsIBA 01/2017
1	Hexosaminidases (Hexosaminidase)IBA 01/2017
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2015
1	W 12IBA 01/2012
1	Azithromycin (Zithromax)FDA LinkGeneric 11/2011

Therapy/Procedure

5	Therapeutics 01/2011 - 02/2003
3	Immunotherapy 08/2020 - 01/2008
1	Nasal Surgical Procedures 08/2020
1	Ambulatory Surgical Procedures (Outpatient Surgery) 08/2020
1	Patient Isolation 01/2020
1	Polypharmacy 01/2017
1	Precision Medicine 01/2016